Boosting amino acid derivative may be a treatment for schizophrenia

Reduced levels of an amino acid called betaine is associated with schizophrenia pathology. Supplementing betaine levels improved cognitive and behavioral deficits in mouse models of schizophrenia. The amino acid also reduced oxidative stress at the molecular level.

from Neuroscience News https://ift.tt/31V0dda